00
Days
00
Hours
00
Minutes
00
Seconds
| TIME | EVENT | SPEAKER |
|---|---|---|
| Moderators: D. Iancu M. Kelly J. Ospel and S. Peschillo | ||
| 07:30 - 08:00 | Welcome Coffee / Tea | |
| 08:00 - 08:20 | Pictorial review of cSDH & meningioma angioarchitecture: implications for embolization | R. Kumar (Pending Confirmation) |
| 08:24 - 08:44 | Evidence of prospective trials on MMAE for cSDH: opportunities and challenges - will stand-alone MMAE become standard of care? | JJ. Shankar |
| 08:48 - 09:08 | cSDH MMAE: Is one agent superior to others? Can we combine MMAE and SDH drainage into one procedure in the angiosuite? | P. Lylyk |
| 09:12 - 09:32 | New generation of magnetically steerable robotic “nanocatheters” and arcuable microwires | P. Mosimann |
| 09:35 - 10:05 | Coffee Break & Industry Booth Visits | |
| Next Moderators: B. Van Adel, R. Fahed and C. Parra-Farinas | ||
| 10:05 - 10:25 | 3D-printed and placenta models: defining the metrics to capture intuition-based practices and improve lifelong learning and teaching of INR techniques (including liquid embolics) | S. Peschillo |
| 10:30 - 12:00 | Recorded 3D printed model techniques for AVMs and MMAE | panel and attendees discussion |
| 12:00 - 13:00 | Lunch | |
| Next Moderators: B. van Adel, D.Tampieri, J. Raymond, F. Arnberg and I. Radovanovic | ||
| 13:00 - 14:00 | KEYNOTE LECTURE: How brain and spine AVMs form, mature and involute - underlying molecular and pharmacological targets | G. Rodesch & I. Radovanovic |
| 14:05 - 14:25 | What is an AVM “nidus”? Concept of venous segmentation and therapeutic considerations | R. Chapot |
| 14:28 - 14:40 | Ahead of the curve: the art and science of wire and microcatheter “shapeology” to increase the chances of successful arterial and venous navigation | R. Chapot |
| 14:43 - 14:55 | Next generation game changer embolic agent for endovascular cure of AVMs and hypervascular tumors | J. Llibre |
| 14:58 - 15:18 | DSA and MR fusion: the key to single session combined TAE/TVE embocure? How easy is it to implement ? | F. Arnberg |
| 15:20 - 15:45 | Coffee Break & Industry Booth Visits | |
| Next Moderators: F. Arnberg, J. Shankar, R. Chapot and T. Darsaut | ||
| 15:48 - 15:55 | Pragmatic care trials on AVMs: natural history and prospective treatment benefit:harm ratio (TOBAS and TATAM) | D. Roy and T. Darsaut |
| 16:00 - 16:12 | Open Q&A and Audience Polling | |
| 16:13 - 16:25 | Most AVMs are surgical: which ones benefit from embolization / hybrid approach? | I. Radovanovic |
| 16:28 - 16:48 | Should we even treat AVMs ? Most/least benefit from SRS alone vs combined SRS-embolization? | B. Karlsson |
| 16:48 - 17:00 | Modern techniques and innovations for fetal and pediatric AV shunts | P. Muthusami |
| 17:00 - 18:00 | 6’ talks on Devices & Innovations |